Inhibition of activin A signalling in a mouse model of pre-eclampsia

Placenta

Volumn 36, Issue 8, 2015, Pages 926-931

  Lim, R ^a,b   Adhikari, S ^a   Gurusinghe, S ^a   Leaw, B ^a,b   Acharya, R ^a   Rahman, R ^a,c   Ciayadi, R ^b   Potdar, M ^b   Kelso, G F ^b   Hearn, M T W ^b   Wallace, E M ^a,b  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Activin signalling; Fetal development; Pre eclampsia; Pregnancy

Indexed keywords

ACTIVIN A; ALBUMIN; CREATININE; SUPEROXIDE; ACTIVIN; ACTIVIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE URINE LEVEL; CROWN RUMP LENGTH; EMBRYO DEATH; EMBRYO DEVELOPMENT; EXTRAVASATION; FEMALE; HUMAN; HUMAN CELL; HYPERTRANSAMINASEMIA; INTRAUTERINE GROWTH RETARDATION; LITTER SIZE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; PREGNANCY;

ACTIVIN RECEPTORS; ACTIVINS; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; MICE; PRE-ECLAMPSIA; PREGNANCY; SIGNAL TRANSDUCTION;

EID: 84938747431     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2015.06.004     Document Type: Article

References (35)

1. C. AbouZahr Global burden of maternal death and disability Br Med Bull 67 2003 1 11
2. K.H. Campbell, D. Savitz, E.F. Werner, C.M. Pettker, D. Goffman, C. Chazotte, and et al. Maternal morbidity and risk of death at delivery hospitalization Obstet Gynecol 122 3 2013 Sep 627 633
3. A.P. MacKay, C.J. Berg, and H.K. Atrash Pregnancy-related mortality from preeclampsia and eclampsia Obstet Gynecol 97 4 2001 Apr 533 538
4. E.K. Main Maternal mortality: new strategies for measurement and prevention Curr Opin Obstet Gynecol 22 6 2010 Dec 511 516
5. J. Chang, L.D. Elam-Evans, C.J. Berg, J. Herndon, L. Flowers, K.A. Seed, and et al. Pregnancy-related mortality surveillance-United States, 1991-1999 MMWR Surveill Summ 52 2 2003 Feb 21 1 8
6. R. Lim, R. Acharya, P. Delpachitra, S. Hobson, C.G. Sobey, G.R. Drummond, and et al. Activin and NADPH-oxidase in preeclampsia: insights from in vitro and murine studies Am J Obstet Gynecol 212 1 2014 Jul 18 86: e1-12
7. S. Luisi, P. Florio, F.M. Reis, and F. Petraglia Expression and secretion of activin A: possible physiological and clinical implications Eur J Endocrinol 145 3 2001 Sep 225 236
8. S. Muttukrishna, P.A. Fowler, L. George, N.P. Groome, and P.G. Knight Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy J Clin Endocrinol Metab 81 9 1996 Sep 3328 3334
9. S. Muttukrishna, P.G. Knight, N.P. Groome, C.W. Redman, and W.L. Ledger Activin A and inhibin A as possible endocrine markers for pre-eclampsia Lancet 349 9061 1997 May 3 1285 1288
10. N.A. Bersinger, A.K. Smárason, S. Muttukrishna, N.P. Groome, and C.W. Redman Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin Hypertens Pregnancy 22 1 2003 45 55
11. C.H. Heldin, K. Miyazono, and P. Dijke ten TGF-beta signalling from cell membrane to nucleus through SMAD proteins Nature 390 6659 1997 Dec 4 465 471
12. C.A. Harrison, P.C. Gray, S.C. Koerber, W. Fischer, and W. Vale Identification of a functional binding site for activin on the type I receptor ALK4 J Biol Chem 278 23 2003 Jun 6 21129 21135
13. K. Tsuchida, M. Nakatani, K. Hitachi, A. Uezumi, Y. Sunada, H. Ageta, and et al. Activin signaling as an emerging target for therapeutic interventions Cell Commun Signal 7 2009 15
14. Y. Zhou, H. Sun, D.C. Danila, S.R. Johnson, D.P. Sigai, X. Zhang, and et al. Truncated activin type I receptor Alk4 isoforms are dominant negative receptors inhibiting activin signaling Mol Endocrinol 14 12 2000 Dec 2066 2075
15. W. Vale, E. Wiater, P. Gray, C. Harrison, L. Bilezikjian, and S. Choe Activins and inhibins and their signaling Ann N Y Acad Sci 1038 2004 Dec 142 147
16. J.M. Yingling, K.L. Blanchard, and J.S. Sawyer Development of TGF-beta signalling inhibitors for cancer therapy Nat Rev Drug Discov 3 12 2004 Dec 1 1011 1022
17. R. Ciayadi, M. Potdar, K.L. Walton, C.A. Harrison, G.F. Kelso, S.J. Harris, and et al. 2-Phenyl and 2-heterocyclic-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridines as inhibitors of TGF-β1 and activin A signalling Bioorg Med Chem Lett 21 18 2011 Sep 15 5642 5645
18. J.Y. Son, S.-Y. Park, S.-J. Kim, S.J. Lee, S.-A. Park, M.-J. Kim, and et al. EW-7197, a novel ALK-5 kinase inhibitor, potently inhibits breast to lung metastasis Mol Cancer Ther 13 7 2014 Jul 1704 1716
19. J.H. Kim, H.-Y. Song, J.-H. Park, H.-J. Yoon, H.G. Park, and D.-K. Kim IN-1233, an ALK-5 inhibitor: prevention of granulation tissue formation after bare metallic stent placement in a rat urethral model Radiology 255 1 2010 Apr 75 82
20. F. Gellibert, A.-C. de Gouville, J. Woolven, N. Mathews, V.-L. Nguyen, C. Bertho-Ruault, and et al. Discovery of 4-{4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): a potent, selective, and orally active transforming growth factor-beta type I receptor inhibitor J Med Chem 49 7 2006 Apr 6 2210 2221
21. J.S. Sawyer, B.D. Anderson, D.W. Beight, R.M. Campbell, M.L. Jones, D.K. Herron, and et al. Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain J Med Chem 46 19 2003 Sep 11 3953 3956
22. D.H. Kozian, M. Ziche, and H.G. Augustin The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis Lab Invest 76 2 1997 Feb 267 276
23. A. Maeshima, Y.Q. Zhang, Y. Nojima, T. Naruse, and I. Kojima Involvement of the activin-follistatin system in tubular regeneration after renal ischemia in rats J Am Soc Nephrol 12 8 2001 Aug 1685 1695
24. T.A. Beyer, M. Narimatsu, A. Weiss, L. David, and J.L. Wrana The TGFβ superfamily in stem cell biology and early mammalian embryonic development Biochim Biophys Acta 1830 2 2013 Feb 2268 2279
25. K.L. Walton, Y. Makanji, and C.A. Harrison New insights into the mechanisms of activin action and inhibition Mol Cell Endocrinol 359 1-2 2012 Aug 15 2 12
26. H. Zhao, K. Oka, P. Bringas, V. Kaartinen, and Y. Chai TGF-beta type I receptor Alk5 regulates tooth initiation and mandible patterning in a type II receptor-independent manner Dev Biol 320 1 2008 Aug 1 19 29
27. V.K. Maurya, R.K. Jha, V. Kumar, A. Joshi, S. Chadchan, J.J. Mohan, and et al. Transforming growth factor-beta 1 (TGF-B1) liberation from its latent complex during embryo implantation and its regulation by estradiol in mouse Biol Reprod 89 4 2013 Oct 84
28. G.M. Horowitz, R.T. Scott, M.R. Drews, D. Navot, and G.E. Hofmann Immunohistochemical localization of transforming growth factor-alpha in human endometrium, decidua, and trophoblast J Clin Endocrinol Metab 76 3 1993 Mar 786 792
29. N. Ando, F. Hirahara, J. Fukushima, S. Kawamoto, K. Okuda, T. Funabashi, and et al. Differential gene expression of TGF-beta isoforms and TGF-beta receptors during the first trimester of pregnancy at the human maternal-fetal interface Am J Reprod Immunol 40 1 1998 Jul 48 56
30. M.Y. Wu, and C.S. Hill Tgf-beta superfamily signaling in embryonic development and homeostasis Dev Cell 16 3 2009 Mar 329 343
31. S. Gurusinghe, E.M. Wallace, and R. Lim The relationship between Activin A and anti-angiogenic factors in the development of pre-eclampsia Pregnancy Hypertens 4 1 2014 Jan 3 6
32. P. Florio, L. Bruni, L. Galleri, F.M. Reis, L.E. Borges, C. Bocchi, and et al. Evaluation of endometrial activin A secretion for prediction of pregnancy after intrauterine insemination Fertil Steril 93 7 2010 May 1 2316 2320
33. R.L. Jones, L.A. Salamonsen, and J.K. Findlay Activin A promotes human endometrial stromal cell decidualization in vitro J Clin Endocrinol Metab 87 8 2002 Aug 4001 4004
34. M.M. Matzuk, T.R. Kumar, and A. Bradley Different phenotypes for mice deficient in either activins or activin receptor type II Nature 374 6520 1995 Mar 23 356 360
35. A. Feijen, M.J. Goumans, and A.J. van den Eijnden-van Raaij Expression of activin subunits, activin receptors and follistatin in postimplantation mouse embryos suggests specific developmental functions for different activins Development 120 12 1994 Dec 3621 3637